Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan I Epstein

Showing results (411-420 of 635) with videos related to

Pageof 64
Sort By:
The American Journal of Surgical Pathology|August 18, 2017
Primary Renal Sarcomas With BCOR-CCNB3 Gene Fusion: A Report of 2 Cases Showing Histologic Overlap With Clear Cell Sarcoma of Kidney, Suggesting Further Link Between BCOR-related Sarcomas of the Kidney and Soft TissuesPedram Argani, Yu-Chien Kao, Lei Zhang, et al.
Urology|February 29, 2008
Natural history of pathologically organ-confined (pT2), Gleason score 6 or less, prostate cancer after radical prostatectomyDavid J Hernandez, Matthew E Nielsen, Misop Han, et al.
Urology|July 3, 2003
Immunohistochemical staining of prostate cancer with monoclonal antibodies to the precursor of prostate-specific antigenTheresa Y Chan, Stephen D Mikolajczyk, Kristin Lecksell, et al.
Journal of the National Cancer Institute|November 6, 2003
Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsiesSusan V Harden, Harriette Sanderson, Steven N Goodman, et al.
The Journal of Urology|March 23, 2011
A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomyPhillip M Pierorazio, Ashley E Ross, Edward M Schaeffer, et al.
The Journal of Urology|August 17, 2018
Older Age Predicts Biopsy and Radical Prostatectomy Grade Reclassification to Aggressive Prostate Cancer in Men on Active SurveillanceSasha C Druskin, Mufaddal Mamawala, Jeffrey J Tosoian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomyEli Rosenbaum, Mohammad Obaidul Hoque, Yoram Cohen, et al.
The American Journal of Surgical Pathology|November 17, 2022
Fibromyxoid Nephrogenic Adenoma: A Series of 43 Cases Reassessing Predisposing Conditions, Clinical Presentation, and MorphologyLin Li, Sean R Williamson, Rosa P Castillo, et al.
The American Journal of Dermatopathology|November 2, 2021
Poorly Differentiated Scrotal Carcinoma With Apocrine ImmunophenotypeSonia Kamanda, Jonathan I Epstein, Adeboye O Osunkoya, et al.
The Journal of Urology|August 19, 2007
Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomyAhmed Magheli, Soroush Rais-Bahrami, Hugh J Peck, et al.
Pageof 64

Showing results (411-420 of 635) with videos related to

Sort By:
Pageof 64
The American Journal of Surgical Pathology|August 18, 2017
Primary Renal Sarcomas With BCOR-CCNB3 Gene Fusion: A Report of 2 Cases Showing Histologic Overlap With Clear Cell Sarcoma of Kidney, Suggesting Further Link Between BCOR-related Sarcomas of the Kidney and Soft TissuesPedram Argani, Yu-Chien Kao, Lei Zhang, et al.
Urology|February 29, 2008
Natural history of pathologically organ-confined (pT2), Gleason score 6 or less, prostate cancer after radical prostatectomyDavid J Hernandez, Matthew E Nielsen, Misop Han, et al.
Urology|July 3, 2003
Immunohistochemical staining of prostate cancer with monoclonal antibodies to the precursor of prostate-specific antigenTheresa Y Chan, Stephen D Mikolajczyk, Kristin Lecksell, et al.
Journal of the National Cancer Institute|November 6, 2003
Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsiesSusan V Harden, Harriette Sanderson, Steven N Goodman, et al.
The Journal of Urology|March 23, 2011
A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomyPhillip M Pierorazio, Ashley E Ross, Edward M Schaeffer, et al.
The Journal of Urology|August 17, 2018
Older Age Predicts Biopsy and Radical Prostatectomy Grade Reclassification to Aggressive Prostate Cancer in Men on Active SurveillanceSasha C Druskin, Mufaddal Mamawala, Jeffrey J Tosoian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomyEli Rosenbaum, Mohammad Obaidul Hoque, Yoram Cohen, et al.
The American Journal of Surgical Pathology|November 17, 2022
Fibromyxoid Nephrogenic Adenoma: A Series of 43 Cases Reassessing Predisposing Conditions, Clinical Presentation, and MorphologyLin Li, Sean R Williamson, Rosa P Castillo, et al.
The American Journal of Dermatopathology|November 2, 2021
Poorly Differentiated Scrotal Carcinoma With Apocrine ImmunophenotypeSonia Kamanda, Jonathan I Epstein, Adeboye O Osunkoya, et al.
The Journal of Urology|August 19, 2007
Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomyAhmed Magheli, Soroush Rais-Bahrami, Hugh J Peck, et al.
Pageof 64